Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients

(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC). N...

Full description

Bibliographic Details
Main Authors: Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/30/2/191